Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
01:36:58 EST Sat 17 Jan 2026
Enter Symbol
or Name
USA
CA



Q:MYGN - MYRIAD GENETICS INC - https://www.myriad.com/
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
MYGN - Q0.14.12·6.700.15.92-0.12-2.01,050.25,8396,7266.04  6.11  5.8815.46  3.7617:32:58Jan 1215 min RT 2¢

Recent Trades - Last 10 of 6726
Time ETExPriceChangeVolume
17:32:58Q5.90-0.146
16:10:04Q5.92-0.121
16:10:04Q5.92-0.121
16:10:04Q5.92-0.121
16:10:04Q5.92-0.121
16:04:52Q5.92-0.121
16:04:29Q5.92-0.121
16:04:27Q5.92-0.121
16:04:23Q5.92-0.121
16:04:14Q5.92-0.121

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2026-01-12 08:30U:MYGNNews ReleaseMyriad Genetics Announces Select Preliminary Fourth Quarter and Full Year 2025 Financial Results and Introduces Full Year 2026 Financial Guidance
2026-01-05 16:15U:MYGNNews ReleaseMyriad Genetics to Present at 44th Annual J.P. Morgan Healthcare Conference
2025-12-09 09:00U:MYGNNews ReleaseMyriad Genetics to Present 8 Abstracts about MRD and Other Studies at 2025 San Antonio Breast Cancer Symposium
2025-11-25 16:15U:MYGNNews ReleaseClairity, Myriad Genetics, and MagView Launch the First Integrated AI and Genetic Risk Platform for Personalized Breast Health
2025-11-11 09:00U:MYGNNews ReleaseMyriad Genetics to Participate in Upcoming Investor Healthcare Conferences
2025-11-10 08:30U:MYGNNews ReleaseMyriad Genetics Adds 15 Clinically Actionable Genes to MyRisk(TM) Hereditary Cancer Test to Support Evolving Clinical Needs
2025-11-06 08:30U:MYGNNews ReleaseMyriad Genetics to Highlight Genetic Testing Advancements at 2025 National Society of Genetic Counselors Annual Conference
2025-11-03 16:05U:MYGNNews ReleaseMyriad Genetics Reports Third Quarter 2025 Financial Results; Reiterates 2025 Financial Guidance Following Continued Solid Execution
2025-10-31 09:05U:MYGNNews ReleaseNew Post-Hoc Analysis Shows Patients Whose Clinicians Had Access to GeneSight Results for Depression Treatment Are More Likely to Feel Better Sooner
2025-10-27 16:15U:MYGNNews ReleaseMyriad Genetics to Release Third Quarter 2025 Financial Results on November 3, 2025
2025-10-14 08:00U:MYGNNews ReleaseMyriad Genetics Adds F8, FXN Genes to Foresight Universal Plus Panel
2025-10-08 17:21U:MYGNNews ReleaseBreast Cancer Awareness Month: Patient and Clinician Share Insights on how to tackle the fear of cancer screenings on YourUpdateTV
2025-09-23 08:01U:MYGNNews ReleaseMyriad Genetics and SOPHiA GENETICS to Develop an Innovative Companion Diagnostic Offering in Liquid Biopsy
2025-09-04 19:00U:MYGNNews ReleaseMyriad Genetics Announces Precise MRD Clinical Data Published in The Lancet Oncology
2025-09-03 16:30U:MYGNNews ReleaseNew Meta-Analysis Demonstrates that Access to the GeneSight Test Can Significantly Improve Response and Remission Rates for Patients with Depression
2025-08-27 16:05U:MYGNNews ReleaseMyriad Genetics to Participate in Upcoming Investor Healthcare Conferences
2025-08-20 02:00U:MYGNNews ReleaseANGLE Announces Collaboration with Myriad Genetics
2025-08-18 08:30U:MYGNNews ReleaseMyriad Genetics Appoints Ben Wheeler Chief Financial Officer